Medicare Enrolled
Dr. Charles D'Auria, D.O.
Family Medicine · Hermitage, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. D'Auria from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. D'Auria?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. D'Auria
Dr. Charles D'Auria is a family medicine specialist in Hermitage, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. D'Auria performed 6,567 Medicare services across 2,053 unique beneficiaries.
Between the years covered by Open Payments, Dr. D'Auria received a total of $16,603 from 66 pharmaceutical and/or device companies across 1207 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. D'Auria is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 1% volume in PA
$16,603 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,567
Medicare services
Top 1% in PA for family medicine
2,053
Unique beneficiaries
$41
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~328 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 2,460 | $18 | $25 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,338 | $60 | $125 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
413 | $38 | $60 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
271 | $35 | $60 |
| Nursing facility visit, established patient, straightforward A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves straightforward medical decision making and lasts at least 10 minutes. |
201 | $28 | $65 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 190 | $20 | $30 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
189 | $29 | $35 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
187 | $58 | $90 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
168 | $1 | $5 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
147 | $91 | $155 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
133 | $123 | $250 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
127 | $123 | $225 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
125 | $88 | $120 |
| Home visit, established patient, straightforward decision making A home visit for an established patient involving straightforward medical decision making. The visit lasts at least 15 minutes when time is used to determine the level of service. |
118 | $27 | $75 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
71 | $10 | $60 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
65 | $36 | $70 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
61 | $29 | $32 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
59 | $282 | $350 |
| Stool test for blood to screen for colon tumors A test that analyzes a stool sample to detect hidden blood, which is used to screen for colon tumors. |
57 | $4 | $10 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
47 | $53 | $140 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
44 | $11 | $40 |
| Annual wellness visit, initial visit A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment. |
29 | $158 | $250 |
| Ear wax removal A procedure to remove impacted ear wax from the ear canal. |
22 | $34 | $65 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
18 | $19 | $85 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
15 | $139 | $180 |
| Vaccine administration The process of giving a vaccine to a patient. This code covers the administration service only and does not include the cost of the vaccine itself. |
12 | $14 | $31 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$16,603
Total received (2018-2024)
Avg $2,372/year across 7 years
Top 3% in PA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
66
Companies
1,207
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,603 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,320
2023
$2,538
2022
$1,983
2021
$2,114
2020
$2,151
2019
$3,041
2018
$2,454
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$373
Lilly USA, LLC
$257
ABBVIE INC.
$214
Amgen Inc.
$182
AstraZeneca Pharmaceuticals LP
$162
Boehringer Ingelheim Pharmaceuticals, Inc.
$154
Novartis Pharmaceuticals Corporation
$141
PFIZER INC.
$105
Novo Nordisk Inc
$87
Bayer Healthcare Pharmaceuticals Inc.
$80
Phathom Pharmaceuticals, Inc.
$75
Otsuka America Pharmaceutical, Inc.
$72
Mylan Specialty L.P.
$71
Esperion Therapeutics, Inc.
$65
E.R. Squibb & Sons, L.L.C.
$53
Merck Sharp & Dohme LLC
$41
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$39
Takeda Pharmaceuticals U.S.A., Inc.
$23
Sumitomo Pharma America, Inc.
$22
Lundbeck LLC
$19
Eisai Inc.
$18
Exact Sciences Corporation
$18
Abbott Laboratories
$18
Kowa Pharmaceuticals America, Inc.
$17
Janssen Pharmaceuticals, Inc
$14
Top 3 companies account for 36.4% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$1,697
AstraZeneca Pharmaceuticals LP
$1,668
GlaxoSmithKline, LLC.
$1,420
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,371
Lilly USA, LLC
$1,293
Janssen Pharmaceuticals, Inc
$935
Amgen Inc.
$733
Novo Nordisk Inc
$725
AbbVie Inc.
$573
Novartis Pharmaceuticals Corporation
$526
Merck Sharp & Dohme Corporation
$451
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$406
ABBVIE INC.
$378
Allergan Inc.
$367
Amarin Pharma Inc.
$366
E.R. Squibb & Sons, L.L.C.
$343
Kowa Pharmaceuticals America, Inc.
$312
Takeda Pharmaceuticals U.S.A., Inc.
$305
Mylan Specialty L.P.
$288
Merck Sharp & Dohme LLC
$271
Allergan, Inc.
$253
SANOFI-AVENTIS U.S. LLC
$183
Teva Pharmaceuticals USA, Inc.
$149
Bayer Healthcare Pharmaceuticals Inc.
$143
Otsuka America Pharmaceutical, Inc.
$117
Ironwood Pharmaceuticals, Inc
$89
Esperion Therapeutics, Inc.
$80
Phathom Pharmaceuticals, Inc.
$75
AbbVie, Inc.
$66
Nestle HealthCare Nutrition Inc.
$57
OPKO Pharmaceuticals, LLC
$54
Shield Therapeutics Inc
$52
Sumitomo Pharma America, Inc.
$51
Alexion Pharmaceuticals, Inc.
$49
Genentech USA, Inc.
$49
Abbott Laboratories
$48
Eisai Inc.
$45
Exact Sciences Corporation
$40
Bayer HealthCare Pharmaceuticals Inc.
$38
Horizon Therapeutics plc
$37
Sunovion Pharmaceuticals Inc.
$35
Amneal Pharmaceuticals LLC
$33
Biohaven Pharmaceuticals, Inc.
$30
Corcept Therapeutics
$28
Avanir Pharmaceuticals, Inc.
$26
Astellas Pharma US Inc
$26
Synergy Pharmaceuticals Inc
$25
Boston Scientific Corporation
$21
Melinta Therapeutics, Inc.
$20
Lundbeck LLC
$19
Xeris Pharmaceuticals, Inc.
$18
IDORSIA PHARMACEUTICALS US INC
$18
Lexicon Pharmaceuticals, Inc.
$17
Pernix Therapeutics Holdings, Inc.
$17
Endo Pharmaceuticals Inc.
$17
Almatica Pharma LLC
$16
Ultragenyx Pharmaceutical Inc.
$16
Daiichi Sankyo Inc.
$15
Biohaven Pharmaceutical Holding Company Ltd.
$14
Supernus Pharmaceuticals, Inc.
$14
Purdue Pharma L.P.
$13
Gilead Sciences, Inc.
$13
Inspire Medical Systems, Inc.
$13
DEXCOM, INC.
$13
Vertical Pharmaceuticals, LLC
$12
Circassia Pharmaceuticals Inc
$11
Top 3 companies account for 28.8% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ADVAIR · AIMOVIG · AJOVY · ANORO · ANORO ELLIPTA · Aimovig · BASAGLAR · BELSOMRA · BEVESPI AEROSPHERE · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · BYSTOLIC · Baxdela · CAMZYOS · CHANTIX · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · Cologuard Collection Kit · Crysvita · DEXCOM G6 TRANSMITTER · DIFICID · Dayvigo · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · FARXIGA · FORTEO · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GARDASIL · GARDASIL 9 · GEMTESA · GLYXAMBI · GRALISE · GVOKE HYPOPEN · INSPIRE · INVOKANA · Inpefa · JANUMET XR · JANUVIA · JARDIANCE · Kerendia · Korlym · LATUDA · LEQVIO · LINZESS · LORZONE · LYRICA · Leqembi · Linzess · Livalo · MOUNJARO · MOVANTIK · MYRBETRIQ · Motegrity · Movantik · NAMZARIC · NASCOBAL · NEXLETOL · NUEDEXTA · NURTEC ODT · OFEV · Otezla · Ozempic · PAXLOVID · PNEUMOVAX 23 · PRADAXA · PRALUENT · PREMARIN · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Prolia · QULIPTA · QUVIVIQ · RAYALDEE · RAYOS · RELISTOR · REXULTI · REYVOW · RYTARY · Repatha · Rybelsus · SHINGRIX · SILENOR · SIVEXTRO · SOLIQUA · SOLIQUA 100/33 · SOLIRIS · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO · STIOLTO RESPIMAT · SYMBICORT · SYMPROIC · SYNTHROID · Soliris · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TROKENDI XR · TRULANCE · TRULICITY · TUDORZA PRESSAIR · Tresiba · Trintellix · Trulance · UBRELVY · VERQUVO · VIBERZI · VIIBRYD · VOQUEZNA · VRAYLAR · VYVANSE · Vascepa · Victoza · WATCHMAN Access System · Wegovy · XARELTO · XIFAXAN · Xofluza · YUPELRI · Yupelri · ZENPEP · ZEPBOUND · ZOMIG · ZORYVE
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 3% for family medicine in PA.
Geographic Context
Family medicine physicians within 10 mi
295
Per 100K population
268.5
County median income
$60,614
Nearest hospital
SHARON REGIONAL MEDICAL CENTER
4.3 mi
4.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. D'Auria is a clinical cardiology specialist, with above-average Medicare volume (top 1% in PA), with low-engagement industry engagement in the top 3% of PA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. D'Auria experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. D'Auria performed 2,460 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. D'Auria receive payments from pharmaceutical companies?
Yes. Dr. D'Auria received a total of $16,603 from 66 companies across 1,207 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. D'Auria's costs compare to other family medicine physicians in Hermitage?
Dr. D'Auria's average Medicare payment per service is $41. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. D'Auria) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Hermitage
Browse family medicine physicians in Hermitage ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in PA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in PA
Which PA family medicine physicians receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology